Xlife Sciences AG
XLS
Company Profile
Business description
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.
Contact
Talacker 35
Zurich8001
CHET: +41 443858460
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
17
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,464.20 | 33.80 | -0.40% |
| CAC 40 | 8,051.07 | 39.92 | -0.49% |
| DAX 40 | 22,410.27 | 15.66 | -0.07% |
| Dow JONES (US) | 43,621.16 | 159.95 | 0.37% |
| FTSE 100 | 8,668.67 | 9.69 | 0.11% |
| HKSE | 23,034.02 | 307.59 | -1.32% |
| NASDAQ | 19,026.39 | 260.54 | -1.35% |
| Nikkei 225 | 38,237.79 | 539.15 | -1.39% |
| NZX 50 Index | 12,441.32 | 134.05 | 1.09% |
| S&P 500 | 5,955.25 | 28.00 | -0.47% |
| S&P/ASX 200 | 8,224.70 | 27.20 | -0.33% |
| SSE Composite Index | 3,346.04 | 26.99 | -0.80% |